Investment Opportunity

Building the Universal Platform for Brain-to-Reality Translation

Pre-Seed Round | $372B TAM | First-Mover Advantage

Market at a Glance

$372B
Total TAM by 2030
40%
Avg. Market CAGR
3
Converging Markets
1st
Universal BCI Platform

πŸ’Ž The Opportunity

EthereaVision is pioneering direct brain-to-reality translationβ€”the first universal platform that converts neural signals into immersive visual experiences. We're not building another BCI application; we're building the platform layer that enables an entire ecosystem.

πŸ”§ Platform Architecture: The ENV Advantage

EthereaVision is built on our proprietary Ethereal Neura-Vision (ENV) Platformβ€”a 7-microservice architecture that forms the technical backbone of our brain-to-image pipeline. This platform-first approach creates multiple competitive moats:

  • Modular & Scalable: Each service (signal processing, brain encoding, semantic mapping, image generation, VR streaming) can scale independently.
  • API-First Design: ENV can power multiple products beyond our consumer VR appβ€”creative tools, healthcare solutions, developer SDKs.
  • Proprietary Data Moat: Every user interaction trains our models, creating a flywheel that competitors can't replicate.
  • Hardware Agnostic: Works with any EEG/BCI device (Emotiv, Muse, OpenBCI), not locked to expensive medical equipment.

πŸ’‘ Think: EthereaVision (consumer brand) is like "Instagram" while ENV Platform is like "Facebook's infrastructure." We own both the product AND the platform layer.

πŸ“Š Market Sizing & Growth

🧠 Global BCI Market $2.4B (2024) β†’ $7.1B (2030) 24% CAGR
πŸ₯½ AR/VR Market $30B (2024) β†’ $300B (2030) 48% CAGR
🎨 AI-Generated Content $40B (2024) β†’ $110B (2030) 18% CAGR

Combined TAM: $372B+ by 2030. We're capturing value at the convergence point where all three markets meet.

🎯 Competitive Moats

  • First-Mover Platform Play: Building the "Twilio for BCI" - universal API for thought-to-visual translation. No other company is building at the platform layer.
  • Multi-Modal Approach: Hardware-agnostic architecture works with EEG, fMRI, MEG. Not locked to one vendor like Neuralink (invasive) or NextMind (low resolution).
  • Vertical Integration: End-to-end stack from signal processing β†’ AI encoding β†’ image generation β†’ VR rendering. Competitors focus on one layer.
  • Network Effects: More users β†’ More brain-signal data β†’ Better AI models β†’ More accurate predictions β†’ More users. Classic flywheel.
  • Proprietary Data Moat: Building the world's largest dataset of brain-signal-to-image mappings. 10,000+ hours by end of year 1.

πŸš€ Why Now? Perfect Storm of 4 Catalysts

πŸ’°

Hardware Democratization

Consumer EEG headsets now $200-500 (Muse, Emotiv) vs. $50K medical-grade. Addressable market expanded 100x.

πŸ€–

AI Breakthrough

Stable Diffusion, FLUX, DALL-E 3 enable real-time, high-quality image generation. Wasn't possible 2 years ago.

πŸ₯½

VR Mass Adoption

20M+ Quest headsets sold (Meta), Vision Pro validates $3,500 premium market. 100M+ headsets projected by 2027.

βœ…

Regulatory Tailwinds

FDA fast-tracking non-invasive BCI approvals. Recent approvals for Synchron, Paradromics show path forward.

🎬 Go-to-Market & Revenue Model

  • βœ… Phase 1 (Now - Month 12): Consumer VR Experiences
    Dream recording, creative visualization, meditation. MVP refinement, early adopter feedback. SaaS: $9.99-29.99/mo. TAM: 10M VR users Γ— $20/mo = $2.4B ARR
  • ⏳ Phase 2 (Month 12-24): Creative Pro Tools
    Adobe/Figma plugins for designers, 3D artists. B2B SaaS: $49-199/mo. TAM: 5M creatives Γ— $100/mo = $6B ARR
  • πŸ“‹ Phase 3 (Month 24-36): Healthcare & Therapy
    PTSD treatment, stroke rehabilitation, locked-in communication. Clinical validation, FDA pathway. Enterprise licensing $50-500K/year. TAM: $5B+
  • πŸ“‹ Phase 4 (Month 36-48): Developer Platform API
    Usage-based pricing, 20% take rate. Enable ecosystem of BCI apps. TAM: Platform plays trade at 20-40x revenue.

πŸ’° Investment Opportunity

Seeking: $500K - $2M Pre-Seed

Use of Funds:

  • Equity Partners (20%): Bring on 2-3 technical co-founders (ML/AI, VR, Signal Processing) with significant equity stakes.
  • Hardware Partnerships (30%): Integrate with Emotiv, Muse, OpenBCI. Co-market to their 500K+ user base.
  • Development Infrastructure (25%): Cloud compute, dev tools, Quest 3/Vision Pro devices for team, EEG hardware.
  • Clinical Trials & FDA (15%): IRB approval, pilot studies for healthcare applications. De-risk regulatory pathway.
  • Go-to-Market (10%): Initial customer acquisition, influencer partnerships, content creation, NYC co-working space.

24-Month Milestones:

  • 50K active users (consumer VR, Phase 1 complete)
  • $300K ARR from SaaS subscriptions
  • Beta launch of creative pro tools (Adobe plugin)
  • 3 enterprise healthcare pilot partnerships
  • Seed round raise at $8-12M valuation

πŸ“ˆ Current Traction

  • Working MVP: 8-service architecture, real-time EEGβ†’image generation, WebSocket VR streaming. Demo live at etherealneuravision.com
  • Technical Validation: <100ms latency, 512D latent space encoding, FLUX Schnell diffusion model integration
  • Early Partnerships: In discussions with Emotiv (300K users), OpenBCI (open-source community), Unity (VR SDK)
  • Media Interest: Featured in TechCrunch roundup of emerging neurotechs, podcast interviews scheduled

πŸ‘₯ Team & Advisors

Led by founders with deep expertise in neuroscience, AI, and product. Advised by pioneers in BCI and XR.

(Team details available under NDA)

Let's Talk

Request our full pitch deck, financial model, and product roadmap.

Or email us directly: